{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Mahil SK"],"funding":["Psoriasis Association","LEO Foundation Skin Immunology Research Center","Manchester Biomedical Research Centre","Medical Research Council","National Institute for Health Research (NIHR)","Wellcome Trust"],"pagination":["60-71"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7566694"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["147(1)"],"pubmed_abstract":["<h4>Background</h4>The multimorbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (COVID-19), but the data are limited.<h4>Objective</h4>Our aim was to characterize the course of COVID-19 in patients with psoriasis and identify factors associated with hospitalization.<h4>Methods</h4>Clinicians reported patients with psoriasis with confirmed/suspected COVID-19 via an international registry, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection. Multiple logistic regression was used to assess the association between clinical and/or demographic characteristics and hospitalization. A separate patient-facing registry characterized risk-mitigating behaviors.<h4>Result"],"journal":["The Journal of allergy and clinical immunology"],"pubmed_title":["Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study."],"pmcid":["PMC7566694"],"funding_grant_id":["HDR-9001","Translational Skin Immunology","PsoProtect","CL-2018-06-006","HDR-9006","MR/T02383X/1","MR/S003126/1","HDR-9002"],"pubmed_authors":["Langan SM","Balogh EA","Valenzuela F","Carolan JE","Smith CH","Yiu ZZN","Makrygeorgou A","van Geest AJ","Rossi MT","Marovt M","Dand N","Cesar GA","De La Cruz C","Genao DR","Celine G","Vandaele M","Magnano M","Hughes J","Dauden E","Ortiz-Salvador JM","Clareus BW","Naldi L","Lesort C","Griffiths CEM","McMahon DE","Carras E","Loayza E","Cummings D","Mercado-Seda R","Essex A","Reeken S","Bachelez H","Rustin M","Kerisit KG","Jullien D","Johnston GA","van Huizen A","Prims CT","Phan C","Panchal M","Klujszo E","Popov G","DeCrescenzo A","Rivera R","Torres T","Puig L","Jones A","Schwartz JJ","Moorhead L","Paolino A","Romiti R","Kirk S","PsoProtect study group","Carrascosa JM","Ayob S","Bewley A","McAteer H","Romero-Mate A","Asfour L","Lakhan M","Quinlan C","Khatun R","Barea A","Speeckaert R","Barker JN","Greco C","Cardozo GA","Eidsmo L","Meynell F","Mwale A","Sonkoly E","Gribben L","Sergeant A","Skov L","Pearson I","Tsakok T","Freeman EE","Velasco M","Goldsmith P","Meuleman L","Mahe E","Barclay C","Zargari O","Mackenzie T","Wu K","Morales Callaghan AM","Varela P","Hampton P","Svensson ML","Lambert J","Piaserico S","de Graaf L","Davis C","Maybury C","Aparicio G","Perez-Barrio S","Toni E","Weisman J","Di Lernia V","Desai TV","Hoey S","Mahil SK","Dwyer E","Gisondi P","Carugno A","Feldman SR","Pink AE","Stefanescu S","Rech G","Brassard D","Martinez A","Hasab VZ","Cohen RW","Taberner R","Franco MD","De Caso P","Choon SE","Martinez-Garcia E","Kolli D","Coker B","Perez-Suarez B","Bak R","Capon F","Woolf R","Singapore A","Jenkin P","King V","Jackson K","Mason KJ","Yanguas I","Spuls P","King G","Hawryluk E","Ceovic R","Di Meglio P","Shah A","Warren RB","Descamps V","Farida B","Talme T","Koreja Z"],"additional_accession":[]},"is_claimable":false,"name":"Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.","description":"<h4>Background</h4>The multimorbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (COVID-19), but the data are limited.<h4>Objective</h4>Our aim was to characterize the course of COVID-19 in patients with psoriasis and identify factors associated with hospitalization.<h4>Methods</h4>Clinicians reported patients with psoriasis with confirmed/suspected COVID-19 via an international registry, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection. Multiple logistic regression was used to assess the association between clinical and/or demographic characteristics and hospitalization. A separate patient-facing registry characterized risk-mitigating behaviors.<h4>Result","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-06-01T00:49:16.19Z","creation":"2021-02-21T11:38:58Z"},"accession":"S-EPMC7566694","cross_references":{"pubmed":["33075408"],"doi":["10.1016/j.jaci.2020.10.007"]}}